LR many thanks for this important posting, I missed it. It clearly shows a company that has a good property in the huge IB market and is moving quickly and firmly towards a completed P-3. It hurts to see all the circling around as the time value of any product dwindles (assuming even, that the IPIX IB formulations will even get through a P-3, though I do feel there is a good chance). Leo seems to walk the edge to try and get the "big payout" but we need to start somewhere, perhaps with a smaller one, sometime. The frustration here is well warranted. Time and progress march on, IPIX does not seem to keep up.
News 
Market Data 
Discover 
